home / stock / dxcm / dxcm articles

DXCM Articles, DexCom Inc. - From 02/07/24

Stock Information
Company Name: DexCom Inc.
Stock Symbol: DXCM
Market: NASDAQ
Website: dexcom.com
Menu
DXCM DXCM Quote DXCM Short DXCM News DXCM Articles DXCM Message Board
Get DXCM Alerts

News, Short Squeeze, Breakout and More Instantly...
If You Invested $100 In This Stock 15 Years Ago, You Would Have $13,000 Today | Benzinga

DexCom (NASDAQ:DXCM) has outperformed the market over the past 15 years by 26.47% on an annualized basis producing an average annual return of 39.0...
Here's How Much $1000 Invested In DexCom 15 Years Ago Would Be Worth Today | Benzinga

DexCom (NASDAQ:DXCM) has outperformed the market over the past 15 years by 28.38% on an annualized basis producing an average annual return of 40.5...

$100 Invested In This Stock 15 Years Ago Would Be Worth $21,000 Today | Benzinga

DexCom (NASDAQ:DXCM) has outperformed the market over the past 15 years by 30.7% on an annualized basis producing an average annual return of 42.6%...

If You Invested $1000 In This Stock 5 Years Ago, You Would Have $3,800 Today | Benzinga

DexCom (NASDAQ:DXCM) has outperformed the market over the past 5 years by 19.36% on an annualized basis producing an average annual return of 30.98...
Here's How Much $100 Invested In DexCom 15 Years Ago Would Be Worth Today | Benzinga

DexCom (NASDAQ:DXCM) has outperformed the market over the past 15 years by 31.26% on an annualized basis producing an average annual return of 42.9...

Industry Comparison: Evaluating DexCom Against Competitors In Health Care Equipment & Supplies Industry | Benzinga

In today's rapidly changing and fiercely competitive business landscape, it is vital for investors and industry enthusiasts to carefully evalu...

If You Invested $100 In This Stock 10 Years Ago, You Would Have $1,300 Today | Benzinga

DexCom (NASDAQ:DXCM) has outperformed the market over the past 10 years by 20.9% on an annualized basis producing an average annual return of 30.18...
Analyzing DexCom In Comparison To Competitors In Health Care Equipment & Supplies Industry | Benzinga

In today's fast-paced and highly competitive business world, it is crucial for investors and industry followers to conduct comprehensive compa...

Barron's Weekend Stock Picks: Verizon, VF Corp And Altria's Dividend Yield | Benzinga

Benzinga reviews this weekend's top stories covered by Barron's. Here are the articles investors need to read. In "Verizon Stock Is Ha...

MedTech Giant DexCom Spotlight Is On G7 US Launch, Analyst Forecasts 22% Revenue Gain In 2024 | Benzinga

Oppenheimer analyst Steven Lichtman reiterated the Outperform rating on DexCom, Inc. (NASDAQ: DXCM), with a reduced price target of ...
Previous 10 Next 10